|
2025
|
Invention
|
Anti-her2/anti-4-1bb bispecific antibody and use thereof.
Provided are an anti-4-1BB/anti-HER2 b... |
|
2024
|
Invention
|
Anti-egfr/anti-4-1bb bispecific antibody and use thereof.
Provided are an anti-4-1BB/anti-EGFR b... |
|
|
Invention
|
7,7-dimethylfuro[3,4-b]pyridin-5(7h)-one derivative or salt thereof, and pharmaceutical compositi... |
|
|
Invention
|
Pyrazolo[3,4-b]pyridine derivative or salt thereof, and pharmaceutical composition comprising sam... |
|
|
Invention
|
Pyrimidine/pyridine derivatives or salts thereof and pharmaceutical compositions comprising the s... |
|
|
Invention
|
Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for prepa... |
|
|
Invention
|
Macrocyclic aminopyridine compounds as egfr inhibitors. The present invention provides novel macr... |
|
|
Invention
|
3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same.
Th... |
|
|
Invention
|
Antigen binding proteins that bind pd-l1.
There is disclosed anti-PD-L1 IgG class antibodies tha... |
|
2023
|
Invention
|
Composition for preventing or treating non-alcoholic fatty liver disease or non-alcoholic steatoh... |
|
|
Invention
|
Dual function proteins and uses thereof. One of the embodiment of the present invention relates t... |
|
|
Invention
|
Novel salt of dimethyl-2,3-dihydro-1h-indene derivative and processes for preparing the same. The... |
|
|
Invention
|
Improved processes for preparing dimethyl-2,3-dihydro-1h-indene derivatives. The present inventio... |
|
|
Invention
|
Long-acting fgf21 fusion proteins and pharmaceutical composition comprising same.
A fusion prote... |
|
|
G/S
|
Cosmetics; cosmetic preparations for skin care and skin treatment; make-up; beauty balm creams; c... |
|
|
G/S
|
Price comparison services; providing information about products via telecommunication networks fo... |
|
|
G/S
|
Cosmetics; cosmetic preparations for skin care and skin
treatment; make-up; beauty balm creams; ... |
|
|
G/S
|
Price comparison services; providing information about
products via telecommunication networks f... |
|
|
Invention
|
Therapies with 3rd generation egfr tyrosine kinase inhibitors.
The present invention relates to ... |
|
|
Invention
|
Process for preparing aminopyrimidine derivatives. The present invention provides an improved pro... |
|
|
Invention
|
Pharmaceutical composition for treating or preventing cancer with low expression level of her2. P... |
|
|
Invention
|
Pharmaceutical composition for treating or preventing cancer with low expression level of her2 |
|
2022
|
Invention
|
Method for producing dual function proteins and its derivatives.
A method for producing a dual f... |
|
|
Invention
|
Synergic combination of 2,3-dioxygenase inhibitor and immune checkpoint inhibitor for the treatme... |
|
|
Invention
|
Bicyclic fused ring derivative or salt thereof and pharmaceutical composition comprising same.
P... |
|
|
Invention
|
Bicyclic fused ring derivative or salt thereof and pharmaceutical composition comprising same. Th... |
|
|
Invention
|
Substituted aminopyridine compounds as egfr inhibitors. Provided are aminopyridine compounds and ... |
|
|
Invention
|
5-membered heteroaryl-containing aminopyridine compounds as egfr inhibitors. Provided are 5-membe... |
|
|
Invention
|
6-membered heteroaryl-containing aminopyridine compounds as egfr inhibitors. Provided are 6-membe... |
|
|
Invention
|
Substituted aminopyridine compounds as egfr inhibitors. The present invention provides novel amin... |
|
|
Invention
|
5-membered heteroaryl-containing aminopyridine compounds as egfr inhibitors. The present inventio... |
|
|
Invention
|
6-membered heteroaryl-containing aminopyridine compounds as egfr inhibitors. The present inventio... |
|
|
Invention
|
Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof. 4 receptor ... |
|
|
Invention
|
Sirp-alpha variants and use thereof. A novel SIRPα (Signal regulatory protein alpha) variant, a f... |
|
|
Invention
|
Ox40 agonist and use thereof.
The present disclosure relates to an OX40 agonist that specificall... |
|
|
Invention
|
Ox40 agonist and use thereof. The present disclosure relates to an OX40 agonist that specifically... |
|
|
Invention
|
Composition for combination therapy comprising growth differentiation factor-15 variant and gluca... |
|
|
Invention
|
Triazolones, tetrazolones, and imidazolones, or their salts, and pharmaceutical compositions comp... |
|
|
Invention
|
Novel indoleamine 2,3-dioxygenase inhibitors, processes for the preparation thereof and pharmaceu... |
|
|
Invention
|
Methods for purifying an anti-4-1bb/anti-her2 bispecific antibody.
Provided is a method for puri... |
|
2021
|
G/S
|
Wholesale store services featuring pharmaceutical products; retail store services featuring pharm... |
|
|
Invention
|
3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same. The... |
|
|
Invention
|
Pharmaceutical compositions comprising a diaminopyrimidine derivative or pharmaceutically accepta... |
|
|
G/S
|
Cosmetics; cosmetic preparations for skin care and skin
treatment; make-up; anti-aging cosmetic ... |
|
|
Invention
|
Engineered antibodies that bind lag3.
The present disclosure provides fully human anti-LAG3 IgG ... |
|
2020
|
G/S
|
Electric devices for attracting and killing insects;
ultrasonic insect killers; non-electronic i... |
|
|
G/S
|
Wholesale services for pharmaceuticals; retail services for
pharmaceuticals; business intermedia... |
|
|
G/S
|
Pharmaceutical preparations; veterinary preparations;
medicines for human purposes; sanitary pre... |
|
|
Invention
|
Long-acting gdf15 fusion protein and pharmaceutical composition comprising same.
A fusion protei... |
|
|
Invention
|
Novel compounds having inhibitory activity against glucosylceramide synthase or pharmaceutically... |
|
|
Invention
|
Novel derivatives having 2,3-dihydro-1h-indene or 2,3-dihydrobenzofuran moiety or pharmaceuticall... |
|
|
Invention
|
Novel derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt... |
|
2015
|
G/S
|
Pharmaceutical preparations; drugs for medical purposes;
medicines for human purposes; analgesic... |
